Rathbones Group PLC Pfizer Inc Transaction History

Rathbones Group PLC

  • $17.8 Billion
  • Q2 2024

A detailed history of Rathbones Group PLC transactions in Pfizer Inc stock. As of the latest transaction made, Rathbones Group PLC holds 595,858 shares of PFE stock, worth $17 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
595,858
Previous 597,260 0.23%
Holding current value
$17 Million
Previous $16.6 Million 0.6%
% of portfolio
0.09%
Previous 0.1%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024
SELL
$25.26 - $29.6 $35,414 - $41,499
-1,402 Reduced 0.23%
595,858 $16.7 Million
Q1 2024

May 14, 2024
SELL
$25.89 - $29.73 $180,246 - $206,980
-6,962 Reduced 1.15%
597,260 $16.6 Million
Q4 2023

Feb 13, 2024
SELL
$26.13 - $33.94 $818,548 - $1.06 Million
-31,326 Reduced 4.93%
604,222 $17.4 Million
Q3 2023

Nov 13, 2023
BUY
$32.09 - $37.51 $4.6 Million - $5.38 Million
143,299 Added 29.11%
635,548 $21.1 Million
Q2 2023

Aug 04, 2023
SELL
$36.12 - $41.79 $220,584 - $255,211
-6,107 Reduced 1.23%
492,249 $18.1 Million
Q1 2023

May 12, 2023
SELL
$39.39 - $51.28 $618,107 - $804,685
-15,692 Reduced 3.05%
498,356 $20.3 Million
Q4 2022

Feb 14, 2023
BUY
$41.75 - $54.5 $554,440 - $723,760
13,280 Added 2.65%
514,048 $26.4 Million
Q3 2022

Nov 03, 2022
SELL
$43.76 - $53.42 $1.48 Million - $1.81 Million
-33,852 Reduced 6.33%
500,768 $21.9 Million
Q2 2022

Aug 12, 2022
BUY
$46.53 - $55.17 $533,047 - $632,027
11,456 Added 2.19%
534,620 $28 Million
Q1 2022

May 11, 2022
SELL
$45.75 - $56.69 $306,067 - $379,256
-6,690 Reduced 1.26%
523,164 $27.1 Million
Q4 2021

Feb 10, 2022
SELL
$41.32 - $61.25 $37,188 - $55,125
-900 Reduced 0.17%
529,854 $31.3 Million
Q3 2021

Nov 04, 2021
SELL
$39.25 - $50.42 $2.61 Million - $3.36 Million
-66,622 Reduced 11.15%
530,754 $22.8 Million
Q2 2021

Jul 30, 2021
SELL
$35.91 - $40.68 $809,124 - $916,601
-22,532 Reduced 3.63%
597,376 $23.4 Million
Q1 2021

May 14, 2021
SELL
$33.49 - $37.77 $1.89 Million - $2.13 Million
-56,289 Reduced 8.32%
619,908 $22.5 Million
Q4 2020

Feb 11, 2021
BUY
$33.47 - $42.56 $47,125 - $59,924
1,408 Added 0.21%
676,197 $24.9 Million
Q3 2020

Nov 13, 2020
BUY
$31.75 - $37.25 $2 Million - $2.34 Million
62,921 Added 10.28%
674,789 $24.8 Million
Q2 2020

Aug 07, 2020
SELL
$30.12 - $36.54 $486,076 - $589,682
-16,138 Reduced 2.57%
611,868 $20 Million
Q1 2020

May 04, 2020
BUY
$27.03 - $38.62 $564,602 - $806,694
20,888 Added 3.44%
628,006 $20.5 Million
Q4 2019

Feb 11, 2020
BUY
$32.92 - $37.36 $423,845 - $481,010
12,875 Added 2.17%
607,118 $23.8 Million
Q3 2019

Nov 13, 2019
BUY
$32.49 - $42.13 $2.73 Million - $3.54 Million
84,086 Added 16.48%
594,243 $21.4 Million
Q2 2019

Aug 12, 2019
BUY
$36.98 - $41.52 $104,912 - $117,792
2,837 Added 0.56%
510,157 $22.1 Million
Q1 2019

May 09, 2019
BUY
$37.5 - $41.2 $943,687 - $1.04 Million
25,165 Added 5.22%
507,320 $21.5 Million
Q4 2018

Feb 12, 2019
BUY
$38.47 - $43.86 $2.23 Million - $2.54 Million
57,981 Added 13.67%
482,155 $21 Million
Q3 2018

Oct 12, 2018
BUY
$34.47 - $41.81 $5.83 Million - $7.07 Million
169,107 Added 66.3%
424,174 $18.7 Million
Q2 2018

Jul 16, 2018
SELL
$32.98 - $35.16 $475,373 - $506,796
-14,414 Reduced 5.35%
255,067 $9.25 Million
Q1 2018

Apr 06, 2018
SELL
$31.91 - $37.02 $24.4 Million - $28.3 Million
-765,043 Reduced 73.95%
269,481 $9.56 Million
Q4 2017

Jan 24, 2018
BUY
$33.26 - $35.29 $106,265 - $112,751
3,195 Added 0.31%
1,034,524 $37.5 Million
Q3 2017

Oct 24, 2017
BUY
$31.0 - $34.15 $32 Million - $35.2 Million
1,031,329
1,031,329 $36.8 Million

Others Institutions Holding PFE

# of Institutions
3,231
Shares Held
3.72B
Call Options Held
73.2M
Put Options Held
108M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $160B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Rathbones Group PLC Portfolio

Follow Rathbones Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rathbones Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Rathbones Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email